MetLife Inc (MET) FinancialsMETMetLife Inc

MetLife, Inc. (MET) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Group Benefits, accounting for 35.9% of total sales, equivalent to $6.87B. Other significant revenue streams include RIS and Asia. Understanding this composition is critical for investors evaluating how MET navigates market cycles within the Life & Health Insurance industry.

Evaluating the bottom line, MetLife, Inc. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 6.93%, while the net margin is 4.07%. These profitability ratios, combined with a Return on Equity (ROE) of 12.48%, provide a clear picture of how effectively MET converts its operational activities into shareholder value.

In the context of the broader market, MET competes directly with industry leaders such as SLF and AFL. With a market capitalization of $62.06B, it holds a leading position in the sector. When comparing efficiency, MET's gross margin of N/A stands against SLF's N/A and AFL's N/A. Such benchmarking helps identify whether MetLife, Inc. is trading at a premium or discount relative to its financial performance.

MetLife's revenue for Q2 2026 was reported at $19.155 billion, with a net income of $705 million, showing solid financial health. The company also has a forward P/E ratio of 11.17, suggesting it is undervalued compared to its earnings potential.